Close
Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
Show source BACK TO LIST

Laboratory Report

Patient
Name: Engelsen, Niklas
DOB: 22-NOV-1989 (Age: 35)
Gender: male
Address:
Fangebakken 35
1788 Berg I Østfold (Norway)
ID: 9839-893540-7
Report
Date: 04-JUN-2022
Laboratory
Requested by
Betesda Spesialistsenter
Rektor Østbyesgate 4.0
1607 Fredrikstad (Norway)
Specimen
Collected: 03-JUN-2022

Chemistry

Test 03 Jun 2022 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.2 H 4.8 - 5.7 %
Glucose [Mass/volume] in Blood 80.2 70 - 100 mg/dL
Urea nitrogen [Mass/volume] in Blood 8.9 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 1.5 H 0.6 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 8.7 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 140.8 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.3 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 101.1 98 - 108 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 22.1 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 146.4 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 131.2 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 61.6 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 58.6 40 - 100 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows elevated HbA1c (6.2%), indicating impaired glucose metabolism or possible prediabetes, and mildly increased creatinine, suggesting possible early renal impairment. Previous labs (2019) showed anemia (low hemoglobin/hematocrit) and abnormal platelet indices, but current data on these is lacking. Lipid profile, electrolytes, and glucose are within normal limits. Recommend follow-up for glycemic control, renal function, and updated complete blood count.